Defects in mitochondrial respiratory complexes III and IV, and human pathologies

Area of Science:

• Biochemistry
• Genetics
• Pathology

Background:

• Respiratory complexes III (cytochrome bc1) and IV (cytochrome c oxidase) are crucial for cellular energy production.
• Deficiencies in these complexes are linked to a spectrum of neuromuscular and non-neuromuscular diseases.
• These deficiencies can arise from mutations in either mitochondrial or nuclear DNA.

Purpose of the Study:

• To review the relationships between genetic mutations affecting respiratory complexes III and IV and human pathologies.
• To explore how alterations in protein structure, activity, and assembly contribute to disease phenotypes.
• To summarize known genetic defects in mitochondrial and nuclear genes impacting these complexes.

Main Methods:

• Literature review of studies on respiratory complex deficiencies and genetic mutations.
• Analysis of reported cases linking mutations to clinical phenotypes.
• Compilation of identified mutations in mitochondrial and nuclear genes.

Main Results:

• Mutations in mitochondrial genes (e.g., cytochrome b, COX subunits) and nuclear genes (e.g., BCS1L, SURF-1, SCO1, SCO2, COX10) are associated with Complex III and IV deficiencies.
• These deficiencies manifest in heterogeneous clinical presentations across various age groups.
• Genetic defects can affect complex assembly, structure, and function, leading to disease.

Conclusions:

• Genetic defects in respiratory complexes III and IV are significant contributors to a range of human diseases.
• Understanding these genetic underpinnings is vital for diagnosing and potentially treating associated pathologies.
• Further research into assembly factors and chaperones is crucial for a comprehensive understanding.